2 options
Genzyme : the Synvisc-One investment decision / Tim Calkins & Ann Deming.
- Format:
- Book
- Author/Creator:
- Calkins, Tim, author.
- Deming, Ann, author.
- Series:
- SAGE knowledge. Cases.
- SAGE Knowledge. Cases.
- SAGE knowledge. Cases
- Language:
- English
- Subjects (All):
- Industrial management--Case studies.
- Industrial management.
- Risk management--Case studies.
- Risk management.
- Genre:
- Case studies.
- Physical Description:
- 1 online resource : illustrations (black and white, and colour).
- Place of Publication:
- [London] : SAGE, 2016.
- System Details:
- text file
- Summary:
- Executives at biotechnology firm Genzyme are debating funding a clinical trial for a new version of a medical device called Synvisc. The trial is expensive and the odds of success are not high, but the upside is substantial. The case presents a common business question: invest or not? The case forces students to think about customer insights, wrestle with a number of complex issues, and evaluate the financials of the decision.
- Notes:
- Originally Published in: Calkins, T., & Deming, A. (2010). Genzyme: The Synvisc-One Investment Decision (Case revised 11/06/2014; TN revised 22/07/2014). 5-110-001. Evanston, IL: Kellogg School of Management, Northwestern University.
- No ILL or scholarly sharing allowed.
- Description based on online resource; title from home page (viewed on April 27, 2016).
- ISBN:
- 9781473959941
- OCLC:
- 1017718633
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.